Literature DB >> 29714009

Epitope Mapping of Antibody-Antigen Interactions with X-Ray Crystallography.

Moeko Toride King1, Cory L Brooks2.   

Abstract

Therapeutic antibodies constitute one of the fastest areas of growth in the field of biologic drugs. A molecular understanding of how antibodies interact with their target antigens is known as epitope mapping. The data provided by epitope mapping is extremely valuable in the process of antibody humanization, as well as in vaccine design. In many cases the epitope recognized by the antibody is a complex, discontinuous 3D conformational epitope. Mapping the interactions of an antibody to a conformational epitope is difficult by many standard approaches. X-ray crystallography is considered to be the gold standard of epitope mapping as it can provide a near atomic resolution model of the antibody-antigen interaction. An X-ray structure allows for inspection of specific antibody-antigen interactions, even in the case of complex conformational epitopes. The method described here can be adapted for structure determination and epitope mapping of any antibody fragment to a simple or complex antigen.

Entities:  

Keywords:  Epitope mapping; Nanobody; Therapeutic antibody; Vaccine

Mesh:

Substances:

Year:  2018        PMID: 29714009      PMCID: PMC6260929          DOI: 10.1007/978-1-4939-7841-0_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Antibodies as leading tools to unlock the therapeutic potential in human disease.

Authors:  Flavius Martin
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 12.988

Review 2.  Engineered protein scaffolds as next-generation antibody therapeutics.

Authors:  Michaela Gebauer; Arne Skerra
Journal:  Curr Opin Chem Biol       Date:  2009-06-06       Impact factor: 8.822

Review 3.  Production and use of antibodies against synthetic peptides.

Authors:  G Walter
Journal:  J Immunol Methods       Date:  1986-04-17       Impact factor: 2.303

4.  Discovery and development of biopharmaceuticals: current issues.

Authors:  William R Strohl; David M Knight
Journal:  Curr Opin Biotechnol       Date:  2009-11-05       Impact factor: 9.740

5.  Epitope mapping by solution NMR spectroscopy.

Authors:  M Bardelli; E Livoti; L Simonelli; M Pedotti; A Moraes; A P Valente; L Varani
Journal:  J Mol Recognit       Date:  2015-02-27       Impact factor: 2.137

Review 6.  Nanobodies: natural single-domain antibodies.

Authors:  Serge Muyldermans
Journal:  Annu Rev Biochem       Date:  2013-03-13       Impact factor: 23.643

Review 7.  Nanobodies as therapeutics: big opportunities for small antibodies.

Authors:  Sophie Steeland; Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Drug Discov Today       Date:  2016-04-11       Impact factor: 7.851

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

Review 10.  Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens.

Authors:  Lassi Liljeroos; Enrico Malito; Ilaria Ferlenghi; Matthew James Bottomley
Journal:  J Immunol Res       Date:  2015-10-07       Impact factor: 4.818

View more
  7 in total

1.  Intact Transition Epitope Mapping - Targeted High-Energy Rupture of Extracted Epitopes (ITEM-THREE).

Authors:  Bright D Danquah; Claudia Röwer; KwabenaF M Opuni; Reham El-Kased; David Frommholz; Harald Illges; Cornelia Koy; Michael O Glocker
Journal:  Mol Cell Proteomics       Date:  2019-05-30       Impact factor: 5.911

2.  ITEM-THREE analysis of a monoclonal anti-malaria antibody reveals its assembled epitope on the pfMSP119 antigen.

Authors:  Kwabena F M Opuni; Cornelia Koy; Manuela Russ; Maren Reepmeyer; Bright D Danquah; Moritz Weresow; Astrid Alef; Peter Lorenz; Hans-Juergen Thiesen; Michael O Glocker
Journal:  J Biol Chem       Date:  2020-08-26       Impact factor: 5.157

Review 3.  Toward rational vaccine engineering.

Authors:  Yashavantha L Vishweshwaraiah; Nikolay V Dokholyan
Journal:  Adv Drug Deliv Rev       Date:  2022-02-09       Impact factor: 15.470

4.  Computational epitope binning reveals functional equivalence of sequence-divergent paratopes.

Authors:  Jarjapu Mahita; Dong-Gun Kim; Sumin Son; Yoonjoo Choi; Hak-Sung Kim; Chris Bailey-Kellogg
Journal:  Comput Struct Biotechnol J       Date:  2022-04-30       Impact factor: 6.155

5.  Direct-MS analysis of antibody-antigen complexes.

Authors:  Shay Vimer; Gili Ben-Nissan; Michael Marty; Sarel J Fleishman; Michal Sharon
Journal:  Proteomics       Date:  2021-08-09       Impact factor: 3.984

6.  Native peptide mapping - A simple method to routinely monitor higher order structure changes and relation to functional activity.

Authors:  Michel Degueldre; Annemie Wielant; Eglantine Girot; Will Burkitt; John O'Hara; Gaël Debauve; Annick Gervais; Carl Jone
Journal:  MAbs       Date:  2019-10-04       Impact factor: 5.857

7.  Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids.

Authors:  Silvia A Camperi; Gerardo Acosta; Gabriela R Barredo; Lucía C Iglesias-García; Cleópatra Alves da Silva Caldeira; María C Martínez-Ceron; Silvana L Giudicessi; Osvaldo Cascone; Fernando Albericio
Journal:  Toxicon X       Date:  2020-05-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.